Trial intelligence / Profile preview

Bevespi on Ventilation and Gas Exchange in COPD

NCT03324607Phase 3Completed

Start
Apr 2018
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of BEVESPI AEROSPHERE in chronic obstructive pulmonary disease (COPD). Started Apr 2018; status: completed.

02

Drugs

BEVESPI AEROSPHERE
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT03324607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03324607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call